Abstract
Sera from guinea pigs given niridazole, an anti-schistosomal compound, have been shown to reversibly block the production of antigen-induced migration inhibitory factor by sensitized guinea pig lymph node cells. Since niridazole itself has no effect in vitro, the blockade of production of migration inhibitory factor is probably due to drug metabolites in the serum. We report here further studies on the mechanism of this drug-induced suppression of cellular hypersensitivity; the data show that niridazole active serum does not block the production of migration inhibitory factor once it has been initiated. Indeed, if niridazole active serum is added a little as 60 sec after the addition of antigen, the lymphocytes will produce migration inhibitory factor. These results suggest the presence of at least two stages in production of migration inhibitory factor after the addition of antigen to lymphocytes. The first, lasting less than 60 sec, is susceptible to blockade by niridazole active serum; the second is not. The elucidation of the mechanism of this blockade should lead to further understanding of the early events after antigen triggering of sensitized lymphocytes.
Full text
PDF



Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bloom B. R., Gaffney J., Jimenez L. Dissociation of MIF production and cell proliferation. J Immunol. 1972 Dec;109(6):1395–1398. [PubMed] [Google Scholar]
- David J. R. Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cell-antigen interaction. Proc Natl Acad Sci U S A. 1966 Jul;56(1):72–77. doi: 10.1073/pnas.56.1.72. [DOI] [PMC free article] [PubMed] [Google Scholar]
- David J. R. Suppression of delayed hypersensitivity in vitro by inhibition of protein synthesis. J Exp Med. 1965 Dec 1;122(6):1125–1134. doi: 10.1084/jem.122.6.1125. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Henney C. S., Gaffney J., Bloom B. R. On the relation of products of activated lymphocytes to cell-mediated cytolysis. J Exp Med. 1974 Sep 1;140(3):837–852. doi: 10.1084/jem.140.3.837. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mahmoud A. A., Mandel A., Warren K., Webster L. T., Jr Niridazole. II. A potent long-acting suppressant of cellular hypersensitivity. J Immunol. 1975 Jan;114(1 Pt 2):279–283. [PubMed] [Google Scholar]
- Mahmoud A. A., Warren K. S. Anti-inflammatory effects of tartar emetic and niridazole: suppression of schistosome egg granuloma. J Immunol. 1974 Jan;112(1):222–228. [PubMed] [Google Scholar]
- Nelson R. D., Leu R. W. Macrophage requirement for production of guinea pig migration inhibitory factor (MIF) in vitro. J Immunol. 1975 Feb;114(2 Pt 1):606–609. [PubMed] [Google Scholar]
- Remold H. G., David R. A., David J. R. Characterization of migration inhibitory factor (MIF) from guinea pig lymphocytes stimulated with concanavalin A. J Immunol. 1972 Sep;109(3):578–586. [PubMed] [Google Scholar]
- Remold H. G., Katz A. B., Haber E., David J. R. Studies on migration inhibitory factor (MIF): recovery of MIF activity after purification by gel filtration and disc electrophoresis. Cell Immunol. 1970 May;1(1):133–145. doi: 10.1016/0008-8749(70)90066-3. [DOI] [PubMed] [Google Scholar]
- Rocklin R. E. Production of migration inhibitory factor by non-dividing lymphocytes. J Immunol. 1973 Mar;110(3):674–678. [PubMed] [Google Scholar]
- Strauss P. R., Berlin R. D. Effects of serum on membrane transport. I. Separation and preliminary characterization of factors which depress lysine or stimulate adenosine transport in rabbit alveolar macrophages. J Exp Med. 1973 Feb 1;137(2):359–368. doi: 10.1084/jem.137.2.359. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wahl S. M., Wilton J. M., Rosenstreich D. L., Oppenheim J. J. The role of macrophages in the production of lymphokines by T and B lymphocytes. J Immunol. 1975 Apr;114(4):1296–1301. [PubMed] [Google Scholar]
- Webster L. T., Jr, Butterworth A. E., Mahmoud A. A., Mngola E. N., Warren K. S. Suppression of delayed hypersensitivity in schistosome-infected patients by niridazole. N Engl J Med. 1975 May 29;292(22):1144–1147. doi: 10.1056/NEJM197505292922202. [DOI] [PubMed] [Google Scholar]
